We are live on ! Find out more
OBIO icon

Orchestra BioMed
OBIO

24 hedge funds and large institutions have $56.6M invested in Orchestra BioMed in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

4% more funds holding

Funds holding: 23 → 24 (+1)

0% more capital invested

Capital invested by funds: $56.4M → $56.6M (+$228K)

0.38% less ownership

Funds ownership: 50.8% → 50.43% (-0.38%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCWM
Graham Capital Wealth Management
District of Columbia
+$647K
2
PCM
PenderFund Capital Management
British Columbia, Canada
+$550K
3
SFM
Spartan Fund Management
Canada
+$266K
4
RL
RPO LLC
Connecticut
+$35.3K

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$1.49M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$386K
3
UBS Group
UBS Group
Switzerland
-$28K
4
Citadel Advisors
Citadel Advisors
Florida
-$13.4K
5
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$9.98M – – –
BlackRock
2
BlackRock
New York
$7.89M – – –
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$6.85M -$386K -38,764 -5%
RCM
4
RA Capital Management
Massachusetts
$6.09M – – –
APM
5
Avidity Partners Management
Texas
$3.99M – – –
EC
6
EcoR1 Capital
California
$3.99M – – –
TCM
7
Tang Capital Management
California
$3.92M – – –
BC
8
Boxer Capital
California
$2.5M -$1.49M -150,000 -38%
SCM
9
Sio Capital Management
New York
$2.5M – – –
DKCM
10
Davidson Kempner Capital Management
New York
$2.45M – – –
Citadel Advisors
11
Citadel Advisors
Florida
$1.7M -$13.4K -1,350 -0.8%
WP
12
Woodline Partners
California
$1.26M – – –
PCM
13
PenderFund Capital Management
British Columbia, Canada
$748K +$550K +55,300 New
GCWM
14
Graham Capital Wealth Management
District of Columbia
$649K +$647K +65,005 New
HF
15
HRT Financial
New York
$498K – – –
TD Asset Management
16
TD Asset Management
Ontario, Canada
$463K – – –
RL
17
RPO LLC
Connecticut
$277K +$35.3K +3,554 +15%
SFM
18
Spartan Fund Management
Canada
$267K +$266K +26,757 New
WRBC
19
W.R. Berkley Corp
Connecticut
$199K – – –
Deutsche Bank
20
Deutsche Bank
Germany
$150K – – –
Geode Capital Management
21
Geode Capital Management
Massachusetts
$124K – – –
ACM
22
Altium Capital Management
New York
$99.8K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$21K – – –
EC
24
Elequin Capital
New York
$15.4K – – –
UBS Group
25
UBS Group
Switzerland
– -$28K -2,824 Closed
1
2

OBIO Hedge Fund Activity: Q4 2022 in Review

24 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Orchestra BioMed (OBIO) for Q4 2022, worth a combined $56.6M — up 0.4% from $56.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new OBIO positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Graham Capital Wealth Management, opening a new position worth an estimated $647K. The largest seller was Boxer Capital, cutting an estimated $1.49M.

  • 24 institutional investors held Orchestra BioMed (OBIO) as of Q4 2022, up from 23 in Q3 2022.
  • Funds reported $56.6M of Orchestra BioMed stock for Q4 2022, up 0.4% quarter-over-quarter.
  • 3 funds opened new Orchestra BioMed positions in Q4 2022 and 2 closed out, a net change of +1 holder.
  • The largest Orchestra BioMed buyer in Q4 2022 was Graham Capital Wealth Management, an estimated $647K added.
  • The largest Orchestra BioMed seller in Q4 2022 was Boxer Capital, an estimated $1.49M sold.

Based on aggregated 13F filings for Q4 2022.